The African Research on Kidney Disease (ARK) Consortium is a multicenter partnership between Malawi, South Africa, Uganda, and the United Kingdom. The study sites for the ARK Consortium are nested wit
Pooled estimate prevalence of chronic kidney disease (CKD) stages 3–5 in low- and middle-income countries (LMICs) by individual countries and in comparison with global mean CKD stages 3–5 prevalence 2